Simian Virus 40 Small t Antigen Mediates Conformation-Dependent Transfer of Protein Phosphatase 2A onto the Androgen Receptor

REFERENCES

• Bakin, R. E., D. Gioeli, R. A. Sikes, E. A. Bissonette, and M. J. Weber. 2003. Constitutive activation of the Ras/mitogen activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate epithelial cells. Cancer Res. 63:1981–1989.
   PubMed Web of Science ®Google Scholar
• Black, B. E., and B. M. Paschal. 2004. Intranuclear organization and function of the androgen receptor. Trends Endocrinol. Metab. 15:411–417.
   PubMed Web of Science ®Google Scholar
• Black, B. E., M. J. Vitto, D. Gioeli, A. Spencer, N. Afshar, M. R. Conaway, M. J. Weber, and B. M. Paschal. 2004. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Mol. Endocrinol. 18:834–850.
   PubMedGoogle Scholar
• Chen, W., R. Possemato, K. T. Campbell, C. A. Plattner, D. C. Pallas, and W. C. Hahn. 2004. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5:127–136.
   PubMed Web of Science ®Google Scholar
• Craft, N., Y. Shostak, M. Carey, and C. L. Sawyers. 1999. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat. Med. 5:280–285.
   PubMed Web of Science ®Google Scholar
• Culig, Z., A. Hobisch, M. V. Cronauer, C. Radmayr, J. Trapman, A. Hittmair, G. Bartsch, and H. Klocker. 1994. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54:5474–5478.
   PubMed Web of Science ®Google Scholar
• Das, D., R. B. Shah, and M. J. Imperiale. 2004. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 23:7031–7046.
   PubMedGoogle Scholar
• Defranco, D. B., A. P. Madan, Y. Tang, U. R. Chandran, N. Xiao, and J. Yang. 1995. Nucleocytoplasmic shuttling of steroid receptors. Vitam. Horm. 51:315–338.
   PubMed Web of Science ®Google Scholar
• Gazdar, A. F., J. S. Butel, and M. S. Carbone. 2002. SV40 and human tumours: myth, association or reality. Nat. Rev. Cancer 2:957–964.
   PubMed Web of Science ®Google Scholar
• Gelmann, E. P. 2002. Molecular biology of the androgen receptor. J. Clin. Oncol. 20:3001–3015.
   PubMed Web of Science ®Google Scholar
• Genevaux, P., F. Lang, F. Schwager, J. V. Vartikar, K. Rundell, J. M. Pipas, C. Georgopoulos, and W. L. Kelley. 2003. Simian virus 40 T antigens and J domains: analysis of Hsp40 cochaperone functions in Escherichia coli. J. Virol. 77:10706–10713.
   PubMedGoogle Scholar
• Gingrich, J. R., R. J. Barrios, M. W. Kattan, H. S. Nahm, M. J. Finegold, and N. M. Greenberg. 1997. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res. 57:4687–4691.
   PubMed Web of Science ®Google Scholar
• Gioeli, D., S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, D. F. Hunt, and M. J. Weber. 2002. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J. Biol. Chem. 277:29304–29314.
   PubMed Web of Science ®Google Scholar
• Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121–141.
   PubMed Web of Science ®Google Scholar
• Groves, M. R., N. Hanlon, P. Turowski, B. A. Hemmings, and D. Barford. 1999. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 96:99–110.
   PubMedGoogle Scholar
• Hahn, W. C., S. K. Dessain, M. W. Brooks, J. E. King, B. Elenbaas, D. M. Sabatini, J. A. DeCaprio, and R. A. Weinberg. 2002. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22:2111–2123.
   PubMed Web of Science ®Google Scholar
• He, B., J. A. Kemppainen, and E. M. Wilson. 2000. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275:22986–22994.
   PubMed Web of Science ®Google Scholar
• Huang, H., and D. J. Tindall. 2002. The role of the androgen receptor in prostate cancer. Crit. Rev. Eukaryot. Gene Expr. 12:193–207.
   PubMed Web of Science ®Google Scholar
• Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:417–439.
   PubMed Web of Science ®Google Scholar
• Kasper, S., P. C. Sheppard, Y. Yan, N. Pettigrew, A. D. Borowsky, G. S. Prins, J. G. Dodd, M. L. Duckworth, and R. J. Matusik. 1998. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab. Investig. 78:319–333.
   PubMed Web of Science ®Google Scholar
• Kelley, W. L. 1998. The J-domain family and the recruitment of chaperone power. Trends Biochem. Sci. 23:222–227.
   PubMed Web of Science ®Google Scholar
• Lange, C. A. 2004. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word. Mol. Endocrinol. 18:269–278.
   PubMedGoogle Scholar
• Lin, H. K., S. Yeh, H. Y. Kang, and C. Chang. 2001. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc. Natl. Acad. Sci. USA 98:7200–7205.
   PubMed Web of Science ®Google Scholar
• McKenna, N. J., and B. W. O'Malley. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465–474.
   PubMed Web of Science ®Google Scholar
• Metivier, R., G. Penot, M. R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751–763.
   PubMed Web of Science ®Google Scholar
• Mungre, S., K. Enderle, B. Turk, A. Porras, Y. Q. Wu, M. C. Mumby, and K. Rundell. 1994. Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation. J. Virol. 68:1675–1681.
   PubMedGoogle Scholar
• Murata, K., J. Wu, and D. L. Brautigan. 1997. B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl. Acad. Sci. USA 94:10624–10629.
   PubMedGoogle Scholar
• Nazareth, L. V., D. L. Stenoien, W. E. Bingman III, A. J. James, C. Wu, Y. Zhang, D. P. Edwards, M. Mancini, M. Marcelli, D. J. Lamb, and N. L. Weigel. 1999. A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1). Mol. Endocrinol. 13:2065–2075.
   PubMedGoogle Scholar
• Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167–176.
   PubMed Web of Science ®Google Scholar
• Porras, A., J. Bennett, A. Howe, K. Tokos, N. Bouck, B. Henglein, S. Sathyamangalam, B. Thimmapaya, and K. Rundell. 1996. A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J. Virol. 70:6902–6908.
   PubMed Web of Science ®Google Scholar
• Pratt, W. B., M. D. Galigniana, Y. Morishima, and P. J. Murphy. 2004. Role of molecular chaperones in steroid receptor action, p. 41–58. In I. J. McEwan (ed.), The nuclear receptor superfamily, vol. 40. Portland Press, London, United Kingdom.
   Google Scholar
• Ruediger, R., M. Hentz, J. Fait, M. Mumby, and G. Walter. 1994. Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens. J. Virol. 68:123–129.
   PubMedGoogle Scholar
• Ruediger, R., D. Roeckel, J. Fait, A. Bergqvist, G. Magnusson, and G. Walter. 1992. Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol. Cell. Biol. 12:4872–4882.
   PubMedGoogle Scholar
• Sack, J. S., K. F. Kish, C. Wang, R. M. Attar, S. E. Kiefer, Y. An, G. Y. Wu, J. E. Scheffler, M. E. Salvati, S. R. Krystek, Jr., R. Weinmann, and H. M. Einspahr. 2001. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc. Natl. Acad. Sci. USA 98:4904–4909.
   PubMed Web of Science ®Google Scholar
• Shao, D., and M. A. Lazar. 1999. Modulating nuclear receptor function: may the phos be with you. J. Clin. Investig. 103:1617–1618.
   PubMed Web of Science ®Google Scholar
• Simental, J. A., M. Sar, M. V. Lane, F. S. French, and E. M. Wilson. 1991. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266:510–518.
   PubMed Web of Science ®Google Scholar
• Sola, M. M., T. Langan, and P. Cohen. 1991. p34cdc2 phosphorylation sites in histone H1 are dephosphorylated by protein phosphatase 2A1. Biochim. Biophys. Acta 1094:211–216.
   PubMedGoogle Scholar
• Sontag, E. 2001. Protein phosphatase 2A: the Trojan horse of cellular signaling. Cell. Signal. 13:7–16.
   PubMed Web of Science ®Google Scholar
• Sontag, E., S. Federov, C. Kamibayashi, D. Robbins, M. Cobb, and M. C. Mumby. 1993. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the Map kinase pathway and induces cell proliferation. Cell 75:887–897.
   PubMed Web of Science ®Google Scholar
• Sontag, E., V. Nunbhakdi-Crai, G. S. Bloom, and M. C. Mumby. 1995. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 128:1131–1134.
   PubMedGoogle Scholar
• Srinivasan, A., A. J. McClellan, J. Vartikar, I. Marks, P. Cantalupo, Y. Li, P. Whyte, K. Rundell, J. L. Brodsky, and J. M. Pipas. 1997. The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol. Cell. Biol. 17:4761–4773.
   PubMedGoogle Scholar
• Strack, S., J. A. Zaucha, F. F. Ebner, R. J. Colbran, and B. E. Wadzinski. 1998. Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits. J. Comp. Neurol. 392:515–527.
   PubMedGoogle Scholar
• Turk, B., A. Porras, M. C. Mumby, and K. Rundell. 1993. The simian virus 40 small-t antigen binds two Zn ions. J. Virol. 67:3671–3673.
   PubMedGoogle Scholar
• Wang, W. B., I. Bikel, E. Marsilio, D. Newsome, and D. M. Livingston. 1994. Transrepression of RNA polymerase II promoters by the simian virus 40 small t antigen. J. Virol. 68:6180–6187.
   PubMedGoogle Scholar
• Watanabe, G., A. Howe, R. J. Lee, C. Albanese, I. W. Shu, A. N. Karnezis, L. Zon, J. Kyriakis, K. Rundell, and R. G. Pestell. 1996. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93:12861–12866.
   PubMed Web of Science ®Google Scholar
• Weigel, N. L., and Y. Zhang. 1998. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76:469–479.
   PubMedGoogle Scholar
• Yang, S. I., R. L. Lickteig, R. Estes, K. Rundell, G. Walter, and M. C. Mumby. 1991. Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol. Cell. Biol. 11:1988–1995.
   PubMedGoogle Scholar
• Yu, J., A. Boyapati, and K. Rundell. 2001. Critical role for SV40 small-t antigen in human cell transformation. Virology 290:192–198.
   PubMedGoogle Scholar
• Yuan, H., T. Veldman, K. Rundell, and R. Schlegel. 2002. Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J. Virol. 76:10685–10691.
   PubMedGoogle Scholar
• Zhou, Z. X., J. A. Kemppainen, and E. M. Wilson. 1995. Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol. Endocrinol. 9:605–615.
   PubMedGoogle Scholar